clinical trials


Clinical Trials Go Open Source with Marc Desgrousilliers, Clinovo

Podcast brought to you by: Assay Depot - the world's largest cloud-based marketplace for research services. With Assay Depot, you can easily find the perfect research service provider and manage your project from anywhere in the world.

Guest:

Marc Desgrousilliers, CTO, Clinovo Bio and Contact Info

Chapters: (Advance the marker)

1:26 Why does open source make sense for clinical trial software?

7:47 What are the objections to adopting open source?

11:12 Will adoption speed up clinical trials?

14:15 Is this the future?

18:16 Do FDA regulations pose special challenges?

22:04 BONUS: Swimming with sharks, literally

We've been tracking the open science movement here at Mendelspod with shows on open access publishing, platforms for collaboration and sharing data, and genome sharing for research. But what about open source software? Does this trend so strong in the IT world translate over to the life sciences. Marc Desgrousilliers, CTO of Clinovo says yes. Marc comes from the world of IT, spending several years at Microsoft where he led the development of Windows' network management. Marc is passionate about open source and the benefits that come from using software that is developed by the larger community. First of all the software has no licensing fees. (Clinovo makes their money on services that go along with the software.) Users are not dependent upon one software vendor. In addition, Marc points out, when software is designed by a large community free of charge, the user/designer volunteers tend to me very passionate about upgrades and development of the software. Are there special issues related to FDA regulation for open source software? Marc tells of his experience with the Clinovo software and of the validation they provide.

Clinical Trials and Social Media with Craig Lipset, Pfizer

Podcast Sponsor: ScienceExchange.com- The Scientific Services Marketplace

Guests:

Craig Lipset, Pfizer Bio and Contact Info

Bridging Listen (5:48) Bridging clinical research with eHealth

<img src="/images/speaker.jpg" alt=What happens when trial patients connect with each other online?"/> Listen (2:09) What happens when trial patients connect online?

How have patients changed Listen (4:01) How have patients changed?

What has Pfizer changed Listen (2:51) What has Pfizer changed?

Challenges with mobile health Listen (4:09) Challenges with mobile health?

How is Pfizer using social media Listen (4:58) How is Pfizer using social media?

Social media guidance Listen (9:44) Social media guidance

Pfizer and innovation Listen (1:28) Pfizer and innovation

Clinical trials in 5 years Listen (5:14) Clinical trials in 5 years

We talk with Craig Lipset of Pfizer about how social media is changing clinical trials. Craig has good support at Pfizer to launch innovative trial programs. At Pfizer he is bridging clinical research with eHealth technologies and exploring the opportunity to further inform and empower both patients and providers in the age of social media. Craig served as Vice President of Program Management at Adnexus Therapeutics and was part of the founding management team for Perceptive Informatics. He is the 2010 recipient of the DIA's Outstanding Service Award.



New to Mendelspod?

We advance life science research, connecting people and ideas.
Register here to receive our newsletter.

or skip signup